Aclarion Stock Performance
| ACON Stock | USD 3.59 0.03 0.83% |
The firm shows a Beta (market volatility) of 0.59, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Aclarion's returns are expected to increase less than the market. However, during the bear market, the loss of holding Aclarion is expected to be smaller as well. At this point, Aclarion has a negative expected return of -0.84%. Please make sure to confirm Aclarion's standard deviation, treynor ratio, as well as the relationship between the Treynor Ratio and day median price , to decide if Aclarion performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Aclarion has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (1.63) | Five Day Return (7.18) | Year To Date Return (27.31) | Ten Year Return (100.00) | All Time Return (100.00) |
Last Split Factor 1:27 | Last Split Date 2025-03-28 |
1 | How Aclarion Inc. stock compares to market leaders - 2025 Technical Overview Low Drawdown Investment Strategies - newser.com | 11/13/2025 |
2 | Will Aclarion Inc. stock return to pre crash levels - July 2025 Levels Verified Chart Pattern Trade Signals - newser.com | 11/19/2025 |
3 | Aclarion Stock Drop Looks Sharp, But How Deep Can It Go - Trefis | 12/05/2025 |
4 | Disposition of 152128 shares by Neal David K of Aclarion subject to Rule 16b-3 | 12/12/2025 |
5 | Aclarion Stock Rating Upgraded by Wall Street Zen | 12/29/2025 |
6 | Morning Market Pulse From Orbit to Biomaterials, Innovation Drives the Tape | 01/08/2026 |
7 | Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028 | 01/13/2026 |
8 | Disposition of tradable shares by Thramann Jeffrey John of Aclarion at 1000.0 subject to Rule 16b-3 | 01/16/2026 |
9 | Aclarion to enroll around 25 percent of patients in CLARITY trial by Q2 - MSN | 01/21/2026 |
| Begin Period Cash Flow | 1 M | |
| Total Cashflows From Investing Activities | -321.9 K |
Aclarion Relative Risk vs. Return Landscape
If you would invest 783.00 in Aclarion on November 1, 2025 and sell it today you would lose (424.00) from holding Aclarion or give up 54.15% of portfolio value over 90 days. Aclarion is currently does not generate positive expected returns and assumes 9.0679% risk (volatility on return distribution) over the 90 days horizon. In different words, 81% of stocks are less volatile than Aclarion, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aclarion Target Price Odds to finish over Current Price
The tendency of Aclarion Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.59 | 90 days | 3.59 | roughly 96.0 |
Based on a normal probability distribution, the odds of Aclarion to move above the current price in 90 days from now is roughly 96.0 (This Aclarion probability density function shows the probability of Aclarion Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Aclarion has a beta of 0.59. This suggests as returns on the market go up, Aclarion average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Aclarion will be expected to be much smaller as well. Additionally Aclarion has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Aclarion Price Density |
| Price |
Predictive Modules for Aclarion
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aclarion. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Aclarion Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Aclarion is not an exception. The market had few large corrections towards the Aclarion's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Aclarion, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Aclarion within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.75 | |
β | Beta against Dow Jones | 0.59 | |
σ | Overall volatility | 1.29 | |
Ir | Information ratio | -0.09 |
Aclarion Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Aclarion for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Aclarion can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Aclarion generated a negative expected return over the last 90 days | |
| Aclarion has high historical volatility and very poor performance | |
| Aclarion has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 45.72 K. Net Loss for the year was (6.99 M) with loss before overhead, payroll, taxes, and interest of (16.6 K). | |
| Aclarion currently holds about 3.79 M in cash with (5.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49. | |
| Aclarion has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Aclarion to enroll around 25 percent of patients in CLARITY trial by Q2 - MSN |
Aclarion Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Aclarion Stock often depends not only on the future outlook of the current and potential Aclarion's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aclarion's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 942.84 | |
| Cash And Short Term Investments | 453.7 K |
Aclarion Fundamentals Growth
Aclarion Stock prices reflect investors' perceptions of the future prospects and financial health of Aclarion, and Aclarion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aclarion Stock performance.
| Return On Equity | -0.88 | ||||
| Return On Asset | -0.44 | ||||
| Operating Margin | (89.89) % | ||||
| Current Valuation | 3.45 M | ||||
| Shares Outstanding | 582.37 K | ||||
| Price To Book | 0.31 X | ||||
| Price To Sales | 56.56 X | ||||
| Revenue | 45.72 K | ||||
| Gross Profit | (16.6 K) | ||||
| EBITDA | (6.26 M) | ||||
| Net Income | (6.99 M) | ||||
| Cash And Equivalents | 3.79 M | ||||
| Cash Per Share | 0.49 X | ||||
| Total Debt | 1.15 M | ||||
| Current Ratio | 3.18 X | ||||
| Book Value Per Share | 24.37 X | ||||
| Cash Flow From Operations | (5.27 M) | ||||
| Earnings Per Share | (12.12) X | ||||
| Market Capitalization | 3.58 M | ||||
| Total Asset | 2.12 M | ||||
| Retained Earnings | (51.26 M) | ||||
| Working Capital | (329.15 K) | ||||
About Aclarion Performance
By examining Aclarion's fundamental ratios, stakeholders can obtain critical insights into Aclarion's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Aclarion is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (7.58) | (7.96) | |
| Return On Capital Employed | (6.54) | (6.21) | |
| Return On Assets | (2.96) | (3.11) | |
| Return On Equity | (8.29) | (7.88) |
Things to note about Aclarion performance evaluation
Checking the ongoing alerts about Aclarion for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aclarion help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aclarion generated a negative expected return over the last 90 days | |
| Aclarion has high historical volatility and very poor performance | |
| Aclarion has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 45.72 K. Net Loss for the year was (6.99 M) with loss before overhead, payroll, taxes, and interest of (16.6 K). | |
| Aclarion currently holds about 3.79 M in cash with (5.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49. | |
| Aclarion has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Aclarion to enroll around 25 percent of patients in CLARITY trial by Q2 - MSN |
- Analyzing Aclarion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aclarion's stock is overvalued or undervalued compared to its peers.
- Examining Aclarion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aclarion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aclarion's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aclarion's stock. These opinions can provide insight into Aclarion's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclarion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Will Health Care Equipment & Supplies sector continue expanding? Could Aclarion diversify its offerings? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aclarion data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (12.12) | Revenue Per Share | Quarterly Revenue Growth 0.761 | Return On Assets | Return On Equity |
Investors evaluate Aclarion using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Aclarion's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Aclarion's market price to deviate significantly from intrinsic value.
Understanding that Aclarion's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aclarion represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Aclarion's market price signifies the transaction level at which participants voluntarily complete trades.